Registration Strip Icon for pro Negocie como um profissional: Aproveite discussões em tempo real e ideias que movimentam o mercado para superar a concorrência.

HSP

Hospira (HSP)

De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NYSE:HSP
DataHoraFonteTítuloCódigoCompanhia
12/07/201316:53Dow Jones NewsMedicines Co. Receives Unfavorable Claim Construction Ruling in Patent SuitNYSE:HSP
10/07/201313:00ZacksHospira Touches 52-week High - Analyst BlogNYSE:HSP
08/07/201316:30Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NYSE:HSP
28/06/201315:05Dow Jones NewsEU Regulators Recommend Approval of Hospira's Remicade CopyNYSE:HSP
28/06/201313:53PR Newswire (US)Hospira to Host Conference Call for Second-Quarter 2013 ResultsNYSE:HSP
28/06/201308:54PR Newswire (US)Hospira's Inflectra™ (infliximab) the first biosimilar monoclonal antibody to receive positive opinion from EMA's CHMP for ...NYSE:HSP
03/06/201315:57PR Newswire (US)Hospira Data on European Biosimilar Epoetin, Retacrit, Affirm Treatment Response, Tolerability in Management of Anemia Second...NYSE:HSP
30/05/201307:33Edgar (US Regulatory)Current Report Filing (8-k)NYSE:HSP
24/05/201313:24Edgar (US Regulatory)Confidential Treatment Order (ct Order)NYSE:HSP
22/05/201315:27Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NYSE:HSP
14/05/201310:00PR Newswire (US)Hospira Reappoints Dr. Sumant Ramachandra Chief Scientific OfficerNYSE:HSP
13/05/201310:13Dow Jones NewsU.S. HOT STOCKS FUTURES: HOT STOCKS TO WATCHNYSE:HSP
08/05/201313:55PR Newswire (US)Hospira Convenes Its 2013 Annual Meeting of ShareholdersNYSE:HSP
06/05/201310:22Dow Jones NewsU.S. HOT STOCK FUTURES: HOT STOCKS TO WATCHNYSE:HSP
01/05/201314:37PR Newswire (Canada)Hospira dévoile sa stratégie mondiale d'appareilsNYSE:HSP
01/05/201309:10ZacksEarnings Beat at Hospira - Analyst BlogNYSE:HSP
01/05/201309:05PR Newswire (US)Hospira Unveils Global Device StrategyNYSE:HSP
01/05/201308:30PR Newswire (US)Hospira Reports First-Quarter 2013 ResultsNYSE:HSP
24/04/201311:36Business WireHospira Marks Five Years of Biosimilars Success at 2013 BIO International ConventionNYSE:HSP
17/04/201312:02PR Newswire (US)Hospira to Present at Upcoming Investor ConferencesNYSE:HSP
15/04/201317:16PR Newswire (US)Hospira Names Matthew R. Stober Senior Vice President of OperationsNYSE:HSP
02/04/201311:16PR Newswire (US)Hospira to Host Conference Call for First-Quarter 2013 ResultsNYSE:HSP
01/04/201317:35Edgar (US Regulatory)Quarterly Schedule of Portfolio Holdings of Registered Management Investment Company (n-q)NYSE:HSP
29/03/201317:18Edgar (US Regulatory)Post-effective Amendment (investment Company, Rule 485(b)) (485bpos)NYSE:HSP
29/03/201317:18Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NYSE:HSP
29/03/201317:07Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NYSE:HSP
25/03/201302:17ZacksBear of the Day: Hospira (HSP) - Bear of the DayNYSE:HSP
19/03/201310:30ZacksPediatric Exclusivity for Hospira's Drug - Analyst BlogNYSE:HSP
18/03/201311:26PR Newswire (US)Hospira Obtains Six Months U.S. Pediatric Exclusivity for Precedex™ (dexmedetomidine HCl) InjectionNYSE:HSP
13/03/201310:25PR Newswire (US)Patented Multi-Therapy Infusion Technology Unveiled as Hospira Launches the Q Core Sapphire™ Device in EuropeNYSE:HSP
 Apresentando as notícias mais relevantes sobre:NYSE:HSP